Rubeena Mian, MD
Psychiatry · Burr Ridge, ILNPI 1225171614
Payments from drug & device makers
Across 859 payments — averaging $102.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$79K
- Takeda Pharmaceuticals U.S.A., Inc.$2K
- Bausch Health US, LLC$1K
- Lundbeck LLC$1K
- Corium, LLC$882
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$615
- plus $3K from 19 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 449 | $78,631 |
| Takeda Pharmaceuticals U.S.A., Inc. | 47 | $2,144 |
| Bausch Health US, LLC | 73 | $1,187 |
| Lundbeck LLC | 69 | $1,071 |
| Corium, LLC | 36 | $882 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 30 | $615 |
| Sunovion Pharmaceuticals Inc. | 25 | $458 |
| Axsome Therapeutics, Inc. | 18 | $420 |
| Alkermes, Inc. | 16 | $368 |
| Johnson & Johnson | 14 | $351 |
| Vanda Pharmaceuticals Inc. | 15 | $346 |
| Otsuka America Pharmaceutical, Inc. | 11 | $194 |
| Adlon Therapeutics L.p. | 9 | $158 |
| Shire North American Group Inc | 9 | $134 |
| Eisai Inc. | 7 | $126 |
| Idorsia Pharmaceuticals US Inc | 6 | $111 |
| Jazz Pharmaceuticals Inc. | 6 | $107 |
| Merck | 4 | $68 |
| Nalpropion Pharmaceuticals LLC | 3 | $56 |
| Neurocrine Biosciences, Inc. | 3 | $54 |
| Neos Therapeutics, LP | 3 | $43 |
| Ironshore Pharmaceuticals Inc. | 2 | $36 |
| Alfasigma USA, Inc. | 2 | $33 |
| Biogen | 1 | $25 |
| Novo Nordisk | 1 | $22 |
How this compares
$87,641 in reported general payments places this provider in the 95th percentile of 1,344 psychiatry providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other psychiatry in Burr Ridge
- Jeffrey RossNorthbrook$10.8M
- Yuhwen ChowChicago$8.5M
- Mark LermanNorthbrook$4.5M
- Danesh AlamWinfield$2.7M
- John ZajeckaSkokie$2.5M
- Riaz BaberNaperville$2.4M
- Michael GreenbaumLibertyville$2.2M
- Sandeep GaonkarNaperville$1.8M
- Jon GrantChicago$1.4M
- David KempOak Lawn$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.